In contrast, although the ICC classifies inv(3)/t(3;3) and other MECOM rearrangements as AML-defining recurrent genetic abnormalities, this system requires >10% marrow or peripheral blood blasts to make a diagnosis. This evidence concerns the gene MECOM and intrahepatic cholangiocarcinoma.